摘要
目的探讨调控胆囊癌细胞内Janus激酶(JAK)/信号转导与转录激活子1(STAT1)信号通路抑制吲哚胺2,3双加氧酶(IDO)表达的作用机制,为解除胆囊癌生物治疗中肿瘤产生的免疫耐受提供理论依据。方法应用γ-干扰素和组蛋白去乙酰化酶抑制剂SAHA处理胆囊癌SGC-996细胞。Western blot方法检测IDO、STAT1以及干扰素调节转录因子1(IRF-1)的表达。用细胞免疫组化和激光共聚焦显微镜观察STATl的人核情况,转染和荧光素酶报告基因分析7激活序列(GAS)和干扰素刺激反应元件(ISRE)的活性。结果胆囊癌细胞中IFN-γ刺激IDO的表达呈剂量和时间依赖性。SAHA抑制IDO的表达呈剂量依赖性。SAHA抑制STAT1的磷酸化和入核,抑制IFN-γ促进的GAS、ISRE和IRF-1的活性。结论抑制人胆囊癌细胞中JAK/STAT1信号通路可导致IDO表达下降,表明调控JAK/STAT1信号通路可能会解除胆囊癌生物治疗中肿瘤产生的免疫耐受。
Objective To investigate the mechanism on JAK/STAT1 signal pathway in SAHA down-regulation of indoleamine 2, 3-dioxygenase (IDO) in gallbladder carcinoma cells. Methods We treated gallbladder carcinoma SGC-996 cells with IFN-γ and SAHA. Western blotting was used to detect the expression of IDO, signal transducer and activator of transcription ] (STAT1) phosphorylation and interferon regulatory factor genes 1 (IRF-1). Confocal microscopy analysis was used to detect STAT1 translocation. Transient transfections and reporter genes assay was used in detecting the acti vation of γ-activated sites (GAS) and interferon stimulated response elements (ISRE). Results IDO expressed in SGC-996 cells in dose and time-dependent manners when stimulated with IFN-γ. SAHA down-regulated the expression of IDO induced by IFN-γ in a dose-dependent manner. SAHA blocked the expression of IRF-I induced by IFN-γ. SAHA inhibited the IFN γ-induced STAT1 phosphorylation and nuclear translocation. SAHA down-regulated IFN-γ-induced activation of GAS and ISRE. Conclusions SAHA may down-regulate IDO expression through inhibiting the activation of members in JAK/STAT1 signal pathway. This may provide a new immunotherapeutic strategy to break tumor immune tolerance in gallbladder carcinoma.
出处
《中华肝胆外科杂志》
CAS
CSCD
北大核心
2011年第10期833-837,共5页
Chinese Journal of Hepatobiliary Surgery
基金
国家自然科学基金资助(30840096)